PDL BioPharma provides Q2 revenue guidance

|About: PDL BioPharma, Inc. (PDLI)|By:, SA News Editor

PDL Biopharma (PDLI +6.1%) says its Q2 top line will come in at $140M which represents ~3% decline yoy but over 4% above the consensus estimate of $134.1M.